| Followers | 74 |
| Posts | 1809 |
| Boards Moderated | 0 |
| Alias Born | 04/02/2010 |
Wednesday, May 23, 2012 4:34:30 PM
Ok just checking, you said they "retired" shares and I thought I may have missed something!
One other posibility is they just go out of business if they didn't get financing to continue.
That is a very small possibility considering they should have a recurring residual income from their affiliates and current search advertises they manage.
Even if they stopped all media buys for their own affiliate advertising for companies like Commmision Junction which they are first tier with, they should continue on in business!
Getting rid of the BOD would save them a ton of money!
One other posibility is they just go out of business if they didn't get financing to continue.
That is a very small possibility considering they should have a recurring residual income from their affiliates and current search advertises they manage.
Even if they stopped all media buys for their own affiliate advertising for companies like Commmision Junction which they are first tier with, they should continue on in business!
Getting rid of the BOD would save them a ton of money!
"All Truth, In The Long Run, Is Only Common Sense Clarified. ~ Thomas H. Huxley
"Facts Do Not Cease To Exist Because They Are Ignored." ~ Aldous Huxley
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
